Release of a soluble form of growth hormone receptors (growth hormone-binding proteins) from human IM-9 cells by proteolytic cleavage

J Biochem. 1995 Sep;118(3):521-5. doi: 10.1093/oxfordjournals.jbchem.a124939.

Abstract

Soluble forms of growth hormone receptors, growth hormone-binding proteins (GH-BPs), with molecular weights of 60 and 55kDa were found to be constitutively released from human IM-9 cells. The release of the GH-BPs was not inhibited by inhibitors of protein synthesis (cycloheximide) and transport (brefeldin A). Down-regulation by human growth hormone or trypsin pretreatment of surface growth hormone receptors abolished the GH-BP release, suggesting that cell-surface human growth hormone receptors are involved in the GH-BP release. Several inhibitors of serine-, thiol-, and acid-proteases did not affect the GH-BP release. EDTA efficiently blocked the GH-BP release. This inhibition by EDTA was restored by addition of Mg(2+) and Co(2+). These results suggest that human GH-BPs are constitutively released by proteolytic cleavage of cell-surface growth hormone receptors by a metalloprotease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brefeldin A
  • Carrier Proteins / metabolism*
  • Cells, Cultured
  • Cycloheximide / pharmacology
  • Cyclopentanes / pharmacology
  • Humans
  • Immunoblotting
  • Lymphocytes / drug effects
  • Lymphocytes / metabolism
  • Peptide Hydrolases / metabolism*
  • Protease Inhibitors / pharmacology
  • Protein Synthesis Inhibitors / pharmacology
  • Solubility

Substances

  • Carrier Proteins
  • Cyclopentanes
  • Protease Inhibitors
  • Protein Synthesis Inhibitors
  • Brefeldin A
  • Cycloheximide
  • Peptide Hydrolases
  • somatotropin-binding protein